AstraZeneca is globally withdrawing its COVID-19 vaccine, Vaxzevria, due to the occurrence of Thrombosis with Thrombocytopenia Syndrome (TTS), a rare but severe side effect.

The vaccine has been linked to at least 81 fatalities in the UK, with a lawsuit claiming it caused additional deaths and injuries.

Despite the withdrawal, AstraZeneca denies any connection between the legal action and their decision, attributing the move to commercial factors and the emergence of new variants requiring updated vaccines.

AstraZeneca has stopped the manufacture and supply of Vaxzevria and is collaborating with regulators to effectively conclude its distribution.

Health officials urge those seeking COVID-19 vaccination to consult healthcare providers for guidance tailored to the evolving landscape of the pandemic.